All Stories

  1. KDM4B inhibition reduces inflammatory cytokines, and thus inflammation and bone destruction.
  2. Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesis
  3. Interrogating alkyl and arylalkylpolyamino (bis)urea and (bis)thiourea isosteres as potent antimalarial chemotypes against multiple lifecycle forms of Plasmodium falciparum parasites
  4. Structure–activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures
  5. Transcriptional Activity of the Islet β Cell Factor Pdx1 Is Augmented by Lysine Methylation Catalyzed by the Methyltransferase Set7/9
  6. Discovery of a new class of histone deacetylase inhibitors with a novel zinc binding group
  7. Epigenetics: Novel Therapeutics Targeting Epigenetics
  8. Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase
  9. P1 and P1′ para-fluoro phenyl groups show enhanced binding and favorable predicted pharmacological properties: Structure-based virtual screening of extended lopinavir analogs against multi-drug resistant HIV-1 protease
  10. 3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors
  11. Design of small molecule epigenetic modulators
  12. Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease
  13. Synthesis and Evaluation of Novel Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1
  14. Histone Deacetylase Inhibition Overcomes Drug Resistance through a miRNA-Dependent Mechanism
  15. Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites
  16. 99 Polyamines Mediate Helicobacter priori-Induced Gastric Carcinogenesis in Gerbils
  17. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines
  18. Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner
  19. Polyamines and cancer: implications for chemotherapy and chemoprevention
  20. Low Molecular Weight Amidoximes that Act as Potent Inhibitors of Lysine-Specific Demethylase 1
  21. Polyamine Drug Discovery. Edited by Patrick Woster and Robert A. Casero, Jr.
  22. Crystal structures of multidrug-resistant HIV-1 protease in complex with two potent anti-malarial compounds
  23. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
  24. Novel Pt(II) and Pd(II) complexes with polyamine analogues: Synthesis and vibrational analysis
  25. Polyamine-based small molecule epigenetic modulators
  26. Polyamine Drug Discovery: Synthetic Approaches to Therapeutic Modulators of Polyamine Metabolism
  27. The Design and Development of Polyamine-Based Analogs with Epigenetic Targets
  28. Symmetrical- and Unsymmetrical Terminally Alkylated Polyamines
  29. Polyamine Drug Discovery
  30. Alternative Spermidine Biosynthetic Route Is Critical for Growth ofCampylobacter jejuniand Is the Dominant Polyamine Pathway in Human Gut Microbiota
  31. Discovery of Novel Alkylated (bis)Urea and (bis)Thiourea Polyamine Analogues with Potent Antimalarial Activities
  32. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis -induced colon tumorigenesis
  33. Knockdown of ornithine decarboxylase antizyme 1 causes loss of uptake regulation leading to increased N 1, N 11-bis(ethyl)norspermine (BENSpm) accumulation and toxicity in NCI H157 lung cancer cells
  34. Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells
  35. Use of Polyamine Derivatives as Selective Histone Deacetylase Inhibitors
  36. Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm
  37. Antiprotozoal/Antiparasitic Agents
  38. (Bis)urea and (Bis)thiourea Inhibitors of Lysine-Specific Demethylase 1 as Epigenetic Modulators
  39. Mechanism-Based Inhibitors of the Aspartyl Protease Plasmepsin II as Potential Antimalarial Agents
  40. ChemInform Abstract: Novel Alkylpolyamine Analogues that Possess Both Antitrypanosomal and Antimicrosporidial Activity.
  41. Suppression of Exogenous Gene Expression by Spermidine/SpermineN1-Acetyltransferase 1 (SSAT1) Cotransfection
  42. Epigenetic Targets and Cancer Drug Discovery
  43. Foreword: American Chemical Society Division of Medicinal Chemistry. Celebrating 100 Years of Excellence
  44. Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes
  45. Design of polyamine-based therapeutic agents: new targets and new directions
  46. Polyamine analogues targeting epigenetic gene regulation
  47. A Small Molecule Polyamine Oxidase Inhibitor Blocks Androgen-Induced Oxidative Stress and Delays Prostate Cancer Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model
  48. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines
  49. Spermine analogue-regulated expression of spermidine/spermine N1-acetyltransferase and its effects on depletion of intracellular polyamine pools in mouse fetal fibroblasts
  50. Recent Advances in the Development of Polyamine Analogues as Antitumor Agents§
  51. A novel histone deacetylase inhibitor prevents IL-1β induced metabolic dysfunction in pancreatic β-cells
  52. A novel histone deacetylase inhibitor prevents IL-1β induced metabolic dysfunction in pancreatic β-cells
  53. Metabolism of an Alkyl Polyamine Analog by a Polyamine Oxidase from the Microsporidian Encephalitozoon cuniculi
  54. Elevated Ornithine Decarboxylase Levels Activate Ataxia Telangiectasia Mutated-DNA Damage Signaling in Normal Keratinocytes
  55. Polyaminohydroxamic Acids and Polyaminobenzamides as Isoform Selective Histone Deacetylase Inhibitors§
  56. Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis
  57. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes
  58. Polyamine-based analogues as biochemical probes and potential therapeutics
  59. Spermine and spermidine mediate protection against oxidative damage caused by hydrogen peroxide
  60. Antiprotozoal Agents (African Trypanosomiasis, Chagas Disease, and Leishmaniasis)
  61. Novel alkylpolyaminoguanidines and alkylpolyaminobiguanides with potent antitrypanosomal activity
  62. Effect of pro-inflammatory cytokines on the toxicity of the arylhydroxylamine metabolites of sulphamethoxazole and dapsone in normal human keratinocytes
  63. Spermine Oxidase SMO(PAOh1), NotN1-Acetylpolyamine Oxidase PAO, Is the Primary Source of Cytotoxic H2O2in Polyamine Analogue-treated Human Breast Cancer Cell Lines
  64. Alkyl-Substituted Polyaminohydroxamic Acids:  A Novel Class of Targeted Histone Deacetylase Inhibitors
  65. Role of p53/p21Waf1/Cip1 in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cells
  66. Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes
  67. A Charge-Deficient Analogue of Spermine with Chelating Properties
  68. Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity
  69. Induction of human spermine oxidase SMO(PAOh1) is regulated at the levels of new mRNA synthesis, mRNA stabilization and newly synthesized protein
  70. Bergamottin contribution to the grapefruit juice?felodipine interaction and disposition in humans
  71. Fundamentals of Medicinal Chemistry By Gareth Thomas. John Wiley and Sons, Ltd., West Sussex, U.K.. 2003. xv + 285 pp. 19 × 24.5 cm. ISBN 0-4708-4307-1. $30.00.
  72. Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells
  73. Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
  74. The role of polyamine catabolism in anti-tumour drug response
  75. The Activator-Binding Site of Onchocerca volvulus S-Adenosylmethionine Decarboxylase, a Potential Drug Target
  76. Chapter 21. New therapies for malaria
  77. Induction of apoptosis in human leukaemic cells by IPENSpm, a novel polyamine analogue and anti-metabolite
  78. Cloning and characterization of the mouse polyamine-modulatedfactor-1 (mPMF-1) gene: an alternatively spliced homologue of the human transcription factor
  79. Cloning and characterization of the mouse polyamine-modulatedfactor-1 (mPMF-1) gene: an alternatively spliced homologue of the human transcription factor
  80. Novel Alkylpolyamine Analogues that Possess Both Antitrypanosomal and Antimicrosporidial Activity
  81. Terminally Alkylated Polyamine Analogues as Chemotherapeutic Agents
  82. A Role for Bioactivation and Covalent Binding within Epidermal Keratinocytes in Sulfonamide-Induced Cutaneous Drug Reactions
  83. Molecular basis for the polyamine-OmpF porin interactions: inhibitor and mutant studies 1 1Edited by G. von Heijne
  84. Erratum: Nairn LM, Lindsay GS, Woster PM, and Wallace HM (2000): Cytotoxicity of novel unsymmetrically substituted inhibitors of polyamine biosynthesis in human cancer cells. J. Cell Physiol 182:209-213.
  85. Cytotoxicity of novel unsymmetrically substituted inhibitors of polyamine biosynthesis in human cancer cells
  86. 1-(N-Alkylamino)-11-(N-ethylamino)-4,8-diazaundecanes:  Simple Synthetic Polyamine Analogues That Differentially Alter Tubulin Polymerization
  87. 6 ́,7 ́-Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein
  88. Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment
  89. 82 Comparison of poryamine analogue toxicity in two cell lines (HL-60 & MCF-7)
  90. The natural polyamine spermine functions directly as a free radical scavenger
  91. Comparison of the In Vitro Cytotoxicity of Hydroxylamine Metabolites of Sulfamethoxazole and Dapsone
  92. Structural Specificity of Polyamines and Polyamine Analogues in the Protection of DNA from Strand Breaks Induced by Reactive Oxygen Species
  93. Synthesis of protected allylic amines via palladium(0)-catalyzed amination of allylic acetates
  94. The role of polyamine catabolism in polyamine analogue-induced programmed cell death
  95. Synthesis and biological evaluation of 6′,7′-dihydroxybergamottin (6,7-DHB), a naturally occurring inhibitor of cytochrome P450 3A4
  96. Structural comparison of alkylpolyamine analogues with potent in vitro antitumor or antiparasitic activity
  97. Synthesis and evaluation of a polyamine phosphinate and phosphonamidate as transition-state analogue inhibitors of spermidine/spermine-N1-acetyltransferase
  98. Photoaffinity Labeling of a Cell Surface Polyamine Binding Protein
  99. S-(5'-Deoxy-5'-adenosyl)-1-aminoxy-4-(methylsulfonio)-2-cyclopentene (AdoMao): An Irreversible Inhibitor of S-Adenosylmethionine Decarboxylase with Potent in Vitro Antitrypanosomal Activity
  100. Irreversible inhibition of human S -adenosylmethionine decarboxylase by the pure diastereomeric forms of S -(5′-deoxy-5′-adenosyl)-1-ammonio-4-methylsulfonio-2-cyclopentene (AdoMac)
  101. Growth and biochemical effects of unsymmetrically substituted polyamine analogues in human lung tumor cells 1
  102. Dapsone-Induced Hematologic Toxicity: Comparison of the Methemoglobin-Forming Ability of Hydroxylamine Metabolites of Dapsone in Rat and Human Blood
  103. α-cyano-substituted analogoues of decarboxylated S-adenosylmethionine as enzyme activated, irreversible inhibitors of S-adenosylmethionine decarboxylase
  104. Preparation of the pure diastereomeric forms of S- (5′-deoxy-5′-adenosyl)-1-ammonio-4-methylsulfonio-2- cyclopentene and their evaluation as irreversible inhibitors of S-adenosylmethionine decarboxylase from Escherichia coli
  105. Synthesis and evaluation of unsymmetrically substituted polyamine analogs as modulators of human spermidine/spermine-N1-acetyltransferase (SSAT) and as potential antitumor agents
  106. Restricted rotation analogs of S-adenosylmethionine: synthesis, evaluation as inhibitors of S-adenosylmethionine decarboxylase, and potential use as selective antitrypanosomal agents
  107. S-(5'-Deoxy-5'-adenosyl)-1-ammonio-4-(methylsulfonio)-2-cyclopentene: a potent, enzyme-activated irreversible inhibitor of S-adenosylmethionine decarboxylase
  108. Restricted rotation analogs of decarboxylated S-adenosylmethionine as inhibitors of polyamine biosynthesis.
  109. Effect of S-adenosyl-1,12-diamino-3-thio-9-azadodecane, a multisubstrate adduct inhibitor of spermine synthase, on polyamine metabolism in mammalian cells
  110. Synthesis and biological evaluation of S-adenosyl-1,12-diamino-3-thio-9-azadodecane, a multisubstrate adduct inhibitor of spermine synthase
  111. Synthesis and biological evaluation of cyclic analogs of l-carnitine as potential agents in the treatment of myocardial ischemia
  112. Polyamine Structure and Synthetic Analogs